MedNation AG (FRA:EIF)
Germany · Delayed Price · Currency is EUR 4.000
0.00 (0.00%)
Last updated: Jun 24, 2026, 8:35 AM CET
MedNation AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 52.77 | 48.76 | 45.33 | 37.55 | 35.8 |
Other Revenue | - | - | - | 1.05 | 0.89 |
| 52.77 | 48.76 | 45.33 | 38.59 | 36.69 | |
Revenue Growth (YoY) | 8.22% | 7.56% | 17.46% | 5.18% | 0.88% |
Cost of Revenue | 40.15 | 37.73 | 33.94 | 31.35 | 29.77 |
Gross Profit | 12.62 | 11.03 | 11.4 | 7.25 | 6.93 |
Selling, General & Admin | 3.67 | 3.48 | 4 | 0.55 | 0.22 |
Other Operating Expenses | 5.45 | 5.33 | 5.08 | 3.62 | 3.12 |
Operating Expenses | 10.54 | 10.11 | 10.24 | 7.58 | 7.71 |
Operating Income | 2.08 | 0.92 | 1.15 | -0.33 | -0.79 |
Interest Expense | -0.6 | -0.73 | -0.78 | -3.01 | -2.9 |
Interest & Investment Income | 0.04 | 0.03 | 0 | 0 | 0 |
Other Non Operating Income (Expenses) | 0.09 | 0.28 | 0.43 | - | 0 |
EBT Excluding Unusual Items | 1.6 | 0.5 | 0.81 | -3.34 | -3.68 |
Gain (Loss) on Sale of Assets | 1.49 | -0.03 | -0.01 | - | - |
Asset Writedown | - | - | - | - | -3.63 |
Other Unusual Items | - | - | - | 1.6 | 3.21 |
Pretax Income | 3.11 | 0.48 | 0.82 | -1.72 | -4.1 |
Income Tax Expense | 0.35 | 0.24 | 0.27 | 0.12 | 0.12 |
Earnings From Continuing Operations | 2.76 | 0.23 | 0.55 | -1.85 | -4.22 |
Minority Interest in Earnings | -0.24 | -0.13 | -0.07 | -0.04 | -0.18 |
Net Income | 2.51 | 0.1 | 0.48 | -1.89 | -4.4 |
Net Income to Common | 2.51 | 0.1 | 0.48 | -1.89 | -4.4 |
Net Income Growth | 2300.69% | -78.25% | - | - | - |
Shares Outstanding (Basic) | 2 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 2 | 3 | 3 | 3 | 3 |
Shares Change (YoY) | -16.37% | -6.94% | - | - | - |
EPS (Basic) | 1.07 | 0.04 | 0.16 | -0.63 | -1.46 |
EPS (Diluted) | 1.07 | 0.04 | 0.16 | -0.63 | -1.46 |
EPS Growth | 2770.79% | -76.63% | - | - | - |
Free Cash Flow | 0.88 | 1.45 | 0.64 | 0.32 | 2.68 |
Free Cash Flow Per Share | 0.38 | 0.52 | 0.21 | 0.10 | 0.89 |
Gross Margin | 23.92% | 22.62% | 25.14% | 18.78% | 18.87% |
Operating Margin | 3.95% | 1.88% | 2.54% | -0.86% | -2.14% |
Profit Margin | 4.76% | 0.21% | 1.06% | -4.89% | -11.99% |
Free Cash Flow Margin | 1.68% | 2.97% | 1.41% | 0.82% | 7.29% |
EBITDA | 3.5 | 2.23 | 2.32 | 0.93 | 1.09 |
EBITDA Margin | 6.64% | 4.58% | 5.11% | 2.41% | 2.96% |
D&A For EBITDA | 1.42 | 1.31 | 1.17 | 1.26 | 1.87 |
EBIT | 2.08 | 0.92 | 1.15 | -0.33 | -0.79 |
EBIT Margin | 3.95% | 1.88% | 2.54% | -0.86% | -2.14% |
Effective Tax Rate | 11.37% | 51.12% | 32.87% | - | - |